I found this to be a very positive announcement. And there was a lot of forward looking financials.
Volppara-alone has had a very strong start to Q2 receiving orders providing new ARR in July 2019 very close to the entire new ARR in Q2 last year.
It’s s little hard to split this out but I believe it was around 700k in ARR last year Q2. Please correct me if I’m wrong.
Another thing I like - Notable deals since the last 4C include one of our biggest Enterprise customers extending for another three years, and the signing of another NZ$1M order, this time for a site on the US East Coast. ....this shows the product is Good!
Finally I really like the 900k noted in Volpara Lung. They spoke about the potential but this shows they are. commercially selling it and will report separately on it...WOW
is VHT the new XRO? They didn’t seem to have any issues raising $55M to expand.
I like what they are doing!
- Forums
- ASX - By Stock
- VHT
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-11
Featured News
Add VHT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online